BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lee JM, Lee HS, Hyun JJ, Choi HS, Kim ES, Keum B, Seo YS, Jeen YT, Chun HJ, Um SH, Kim CD. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. World J Gastrointest Oncol 2016; 8(7): 555-562 [PMID: 27559435 DOI: 10.4251/wjgo.v8.i7.555]
URL: https://www.wjgnet.com/1948-5204/full/v8/i7/555.htm
Number Citing Articles
1
Yavuz Karabağ, Metin Çağdaş, Ibrahim Rencuzogullari, Süleyman Karakoyun, İnanç Artaç, Doğan İliş, Eray Atalay, Mahmut Yesin, Mustafa Ozan Gürsoy, Ibrahim Halil Tanboğa. Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectorisJournal of Clinical Laboratory Analysis 2018; 32(7): e22457 doi: 10.1002/jcla.22457
2
Chiou Yi Ho, Zuriati Ibrahim, Zalina Abu Zaid, Zulfitri 'Azuan Mat Daud, Nor Baizura Md Yusop. Clinical malnutrition predictive model among gynecologic cancer patients prior to elective operation: A cross-sectional studyClinical Nutrition 2021; 40(6): 4373 doi: 10.1016/j.clnu.2021.01.008
3
Baoshan Di, Bei Pan, Long Ge, Jichun Ma, Yiting Wu, Tiankang Guo. Targeted agents for patients with advanced/metastatic pancreatic cancerMedicine 2018; 97(13): e0115 doi: 10.1097/MD.0000000000010115
4
Wendi Li, Lianyuan Tao, Meng Lu, Dianrong Xiu. Prognostic role of platelet to lymphocyte ratio in pancreatic cancersMedicine 2018; 97(8): e9616 doi: 10.1097/MD.0000000000009616
5
Riki Ohno, Ryuichi Kawamoto, Mami Kanamoto, Jota Watanabe, Masahiko Fujii, Hiromi Ohtani, Masamitsu Harada, Teru Kumagi, Hideki Kawasaki. Neutrophil to Lymphocyte Ratio is a Predictive Factor of Malignant Potential for Intraductal Papillary Mucinous Neoplasms of the pancreasBiomarker Insights 2019; 14: 117727191985150 doi: 10.1177/1177271919851505
6
Elisabeth S. Gruber, Gerd Jomrich, Alexandra Kaider, Michael Gnant, Klaus Sahora, Martin Schindl. The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing ResectionAnnals of Surgical Oncology 2020; 27(6): 2017 doi: 10.1245/s10434-019-08161-6
7
Byung Min Lee, Seung Yeun Chung, Jee Suk Chang, Kyong Joo Lee, Jinsil Seong. The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with ChemoradiotherapyGut and Liver 2018; 12(3): 342 doi: 10.5009/gnl17216
8
Ye Zang, Yu Fan, Zhenjun Gao. Pretreatment C-reactive protein/albumin ratio for predicting overall survival in pancreatic cancerMedicine 2020; 99(23): e20595 doi: 10.1097/MD.0000000000020595
9
Shinichi Ikuta, Tsukasa Aihara, Naoki Yamanaka. Preoperative C‐reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinomaAsia-Pacific Journal of Clinical Oncology 2019; 15(5) doi: 10.1111/ajco.13123
10
Arturs Silovs, Ilze Strumfa, Reinis Riekstins, Zane Simtniece, Andrejs Vanags, Janis Gardovskis. Advances in Pancreatic Cancer2018;  doi: 10.5772/intechopen.78954
11
Qinfen Xie, Lidong Wang, Shusen Zheng. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-AnalysisDose-Response 2020; 18(2): 155932582093129 doi: 10.1177/1559325820931290
12
Yan-Jun Fu, Ke-Zhi Li, Ji-Hong Bai, Zhi-Qing Liang. C-reactive protein/albumin ratio is a prognostic indicator in Asians with pancreatic cancersMedicine 2019; 98(48): e18219 doi: 10.1097/MD.0000000000018219
13
Lin Zhou, Jing Wang, Xin-xue Zhang, Shao-cheng Lyu, Li-chao Pan, Guo-sheng Du, Ren Lang, Qiang He. Prognostic Value of Preoperative NLR and Vascular Reconstructive Technology in Patients With Pancreatic Cancer of Portal System Invasion: A Real World StudyFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.682928
14
Yoshikane Yamauchi, Seyer Safi, Thomas Muley, Arne Warth, Felix J.F. Herth, Hendrik Dienemann, Hans Hoffmann, Martin E. Eichhorn. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patientsLung Cancer 2017; 114: 62 doi: 10.1016/j.lungcan.2017.11.002
15
Zheng-Shui Xu, Fa-Peng Zhang, Yin Zhang, Yong-Peng Ou-Yang, Xiao-Wen Yu, Wen-Long Wang, Wen-Ji Xu, Zhi-Qiang Luo. Prognostic role of the pre-treatment platelet-lymphocyte ratio in pancreatic cancer: a meta-analysisOncotarget 2017; 8(58): 99003 doi: 10.18632/oncotarget.20871
16
Imad Radi, Ramy Samaha, Joanna El Hajj, Hady Samaha, Hampig Raphael Kourie. Perioperative chemotherapy with modified FOLFIRINOX for nonmetastatic pancreatic cancer: a new standard of care?Future Oncology 2021; 17(3): 229 doi: 10.2217/fon-2020-0836
17
Anna M. Nurmi, Harri K. Mustonen, Ulf-Håkan Stenman, Hanna E. Seppänen, Caj H. Haglund. Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinomaScientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80778-0
18
Yongping Zhou, Qian Wei, Junsheng Fan, Sijin Cheng, Wenzhou Ding, Zhiyuan Hua. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patientsClinica Chimica Acta 2018; 479: 181 doi: 10.1016/j.cca.2018.01.024
19
Caitlin A. McIntyre, Alessandra Pulvirenti, Sharon A. Lawrence, Kenneth Seier, Mithat Gonen, Vinod P. Balachandran, T. Peter Kingham, Michael I. D'Angelica, Jeffrey A. Drebin, William R. Jarnagin, Peter J. Allen. Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the PancreasPancreas 2019; 48(6): 832 doi: 10.1097/MPA.0000000000001342
20
Ionut Negoi, Mircea Beuran, Sorin Hostiuc, Alaa El-Hussuna, Enrique de-Madaria. Platelet-to-lymphocyte ratio and CA19-9 are simple and informative prognostic factors in patients with resected pancreatic cancerHepatobiliary & Pancreatic Diseases International 2019; 18(3): 203 doi: 10.1016/j.hbpd.2019.03.011
21
Feng Yang, Chen Jin, De-Liang Fu, Andrew L Warshaw. Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challengesWorld Journal of Gastroenterology 2019; 25(23): 2839-2845 doi: 10.3748/wjg.v25.i23.2839
22
Jiayuan Wu, Wenkai Tan, Lin Chen, Zhe Huang, Shao Mai. Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysisOncotarget 2018; 9(17): 13934 doi: 10.18632/oncotarget.24172
23
Akhil Chawla, Tiffany L. Huang, Andrew M. Ibrahim, Jeffrey M. Hardacre, Christopher Siegel, John B. Ammori. Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancerHPB 2018; 20(5): 398 doi: 10.1016/j.hpb.2017.10.011
24
Jing Zhang, Chenbo Zhang, Qingxian Li, Jiawen Zhang, Xiaoli Gu, Weiwei Zhao, Menglei Chen, Minghui Liu, Zhe Zhang, Xinghe Liao, Wenwu Cheng. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative CareJournal of Palliative Medicine 2019; 22(12): 1536 doi: 10.1089/jpm.2019.0102
25
Dongwook Oh, Jung-Soo Pyo, Byoung Kwan Son. Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte RatioGastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/9745601
26
Feng Yang, Yun Bao, Zhongwen Zhou, Chen Jin, Deliang Fu. Preoperative neutrophil‐to‐lymphocyte ratio predicts malignancy and recurrence‐free survival of solid pseudopapillary tumor of the pancreasJournal of Surgical Oncology 2019;  doi: 10.1002/jso.25484